2 completed, 2 recruiting. 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Grade IV Glioma: new trials by email Literature Review of Grade IV Glioma trials Research Report on Grade IV Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors temozolomide - Brain Tumor, Grade III Glioma | Recruiting | NanoAlvand | 100 | 2026-03-22 | 2026-06-30 | |
| Implantable Microdevice In Primary Brain Tumors Microdevice - Grade II Glioma, Grade III Glioma | Early Phase 1 | Recruiting | Oliver Jonas | 30 | 2020-03-03 | 2026-10-21 |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma MDNA55 - Glioblastoma, Grade IV Astrocytoma | Phase 2 | Completed | Medicenna Therapeutics, Inc. | 47 | 2017-04-11 | 2022-10-24 |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma TVI-Brain-1 - Grade IV Glioma, Grade IV Astrocytoma | Phase 2 | Completed | TVAX Biomedical | 14 | 2011-06-01 | 2023-07-03 |
Brain Neoplasms (3) · Glioblastoma (3) · Glioma (3) · Astrocytoma (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Oligodendroglioma (1)
Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Neuroectodermal Tumors (4) · Neoplasms (3) · Neoplasms by Site (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Astrocytoma (1) · Glioma (1)
Adjuvants, Immunologic (1) · Cancer Vaccines (1) · Temozolomide (1) · interleukin-4-Pseudomonas exotoxin (1)
Medicenna Therapeutics, Inc. (1) · NanoAlvand (1) · Oliver Jonas (1) · TVAX Biomedical (1)
United States (3) · Iran (1)
Gary Wood, Ph.D. (1) · Pier Paolo Peruzzi, MD, PhD (1)